Search - tctmd.com

Displaying 261 - 280 of 403

Sort: Relevancy | Date

Presentation CCVVC 2015

Future Therapeutic Options in the Management of CLI

Presenter: D. Scheinert

June 18, 2015

Presentation CCVVC 2015

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Presenter: Craig M. Walker

June 18, 2015

Presentation CCVVC 2015

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Presenter: Suhail Dohad

June 18, 2015

Presentation CCVVC 2015

Drug Coated Balloon in the Management of SFA Disease: Data & Current Trends

Presenter: Fabrizio Fanelli

June 18, 2015

Presentation TVT 2015

Thoughtful Commentary: Poor Femoral (Alternative) Access and TAVR

Presenter: Neil E. Moat, Allan Schwartz, Michael J. Reardon

June 05, 2015

Presentation TVT 2015

Case Presentation: Poor Femoral (Alternative) Access and TAVR

Presenter: Neil E. Moat, Allan Schwartz, Mayra Guerrero

June 05, 2015

Presentation Fellows 2015

Femoral vs Radial: A Critical Appraisal of the Evidence, and What You Need to Learn as a Trainee to Do Both Well

Presenter: Manish A. Parikh, Kevin J. Croce, Robert W. Yeh

May 15, 2015

Presentation Fellows 2015

Femoral Vascular Access and Closure (Manual and Device Based): A Step-by-Step Approach

Presenter: Manish A. Parikh, Kevin J. Croce, Zoltan G. Turi

May 15, 2015

Presentation

Comparison of QoL Measures After Radial vs Femoral Artery Access for Cardiac Cath in Women

Presenter: Connie N. Hess

May 14, 2015

Presentation

Radial vs Femoral Access for Coronary Angiography, Intervention in Women With ACS

Presenter: S. Pandie

April 21, 2015

Presentation ISET 2015

Recanalization of SFA Popliteal Arteries: Flossing and Other Solutions

Presenter: Alan H. Matsumoto

February 02, 2015

Presentation ISET 2015

New Insights from the IN.PACT SFA Randomized Trial

Presenter: Gunnar Tepe

February 02, 2015

Presentation ISET 2015

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Presenter: Gunnar Tepe

February 02, 2015

Presentation ISET 2015

Results of Approved DCB in the United States

Presenter: Gary M. Ansel

February 01, 2015

Presentation ISET 2015

Benefits of DCB in SFA Disease

Presenter: Thomas Zeller

February 01, 2015

Presentation ISET 2015

Achieving Re-entry in the Femoral Popliteal Segment

Presenter: Robert Lookstein

January 30, 2015

Presentation

DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD

Presenter: G. Tepe

December 15, 2014

Presentation Cardiovascular Interventions 2014

Recognizing and Managing Femoral Access Site Complications

Presenter: Curtiss T. Stinis

October 22, 2014

Presentation

German Multicenter Real-World Registry of Stenting for SFA Disease

Presenter: Hans Krankenberg

October 01, 2014

Presentation TCT 2014

Case Presentation

Presenter: Sahil A. Parikh

September 17, 2014

Advertisement

Future Therapeutic Options in the Management of CLI

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Drug Coated Balloon in the Management of SFA Disease: Data & Current Trends

Thoughtful Commentary: Poor Femoral (Alternative) Access and TAVR

Case Presentation: Poor Femoral (Alternative) Access and TAVR

Femoral vs Radial: A Critical Appraisal of the Evidence, and What You Need to Learn as a Trainee to Do Both Well

Femoral Vascular Access and Closure (Manual and Device Based): A Step-by-Step Approach

Comparison of QoL Measures After Radial vs Femoral Artery Access for Cardiac Cath in Women

Radial vs Femoral Access for Coronary Angiography, Intervention in Women With ACS

Recanalization of SFA Popliteal Arteries: Flossing and Other Solutions

New Insights from the IN.PACT SFA Randomized Trial

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Results of Approved DCB in the United States

Benefits of DCB in SFA Disease

Achieving Re-entry in the Femoral Popliteal Segment

DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD

Recognizing and Managing Femoral Access Site Complications

German Multicenter Real-World Registry of Stenting for SFA Disease

Case Presentation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content